OVCAR-4 Cells
General information
| Organism | Homo sapiens (Human) |
|---|---|
| Tissue | Metastatic |
| Disease | High grade ovarian serous adenocarcinoma |
| Metastatic site | Ascites |
| Synonyms | OVCAR 4, NIH:OVCAR-4, NIH:OVCAR4, OVCAR.4, OVCAR4, Ovcar4 |
Characteristics
| Age | 42Y |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
Regulatory Data
| Citation | OVCAR-4 (Cytion catalog number 305912) |
|---|---|
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1627 |
Biomolecular Data
| Mutational profile | Mutation: p.Leu130Val, Homozygous |
|---|
Handling
| Doubling time | 34 hours ; 43 hours ; 41.4 hours |
|---|---|
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Metastatic site: | Ascites |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305912-040326 | Certificate of Analysis | 31. Mar. 2026 | 305912 |